Project Number 5R21AG030718-02 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for HIGH-THROUGHPUT COMPOUND SCREENING FOR MODULATORS OF INSULIN-DEGRADING ENZYME. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator LEISSRING, MALCOLM A Principal Investigator First Name MALCOLM A Principal Investigator Last Name LEISSRING Awardee Organization MAYO CLINIC JACKSONVILLE Awardee State Florida Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-06-261: Grants for Alzheimer's Disease Drug Discovery (R21) FY Overall Cost $188,190 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States
